Human Bone Marrow Mononuclear Cells (BMMCs)

About Human Bone Marrow Mononuclear Cells (BMMCs)

Human Bone Marrow Mononuclear Cells for Hematology and Oncology Research

Human bone marrow mononuclear cells (BMMCs) for research are isolated by density-gradient separation from bone marrow aspirate collected from consented donors under IRB-approved protocols, each with a clinically confirmed healthy or disease-state diagnosis. These BMMC samples — including normal human BMMCs from healthy donors and disease-state BMMCs from hematologic malignancy donors — support minimal residual disease research, stem and progenitor cell biology, immunophenotyping, and translational hematology-oncology studies. As a trusted bone marrow biospecimen supplier, Sanguine sources these BMMC specimens to match your protocol. Request custom sourcing below.

What Are Bone Marrow Mononuclear Cells (BMMCs)?

Bone marrow mononuclear cells are the nucleated cell fraction of bone marrow aspirate, isolated by density-gradient centrifugation to remove granulocytes and red blood cells. Unlike peripheral blood mononuclear cells (PBMCs), BMMCs capture the full hierarchy of marrow-resident hematopoietic stem cells, progenitor cells, and precursor cells at all stages of maturation — the population directly relevant to diagnosing and studying hematologic malignancies that originate in the marrow itself. For peripheral blood-derived mononuclear cells instead, see our human PBMCs collection.

Normal (Healthy) Human Bone Marrow Mononuclear Cells

Normal human BMMCs — also called healthy human bone marrow mononuclear cells — come from screened donors with no diagnosed hematologic condition, and serve as the standard control matrix for marrow-based assay development and the baseline arm in case-control designs. Available as:

• Single-donor normal BMMCs — preserves individual variation and supports donor-level demographic linkage
• Demographically matched controls — age- and sex-matched to a disease cohort, the correct comparator rather than convenience controls

Cell Quantities and Format

• Standard cell quantities from 5 x 10^6 cells per vial upward
• Custom cell quantities available to match assay scale
• Cryopreserved for viability on thaw; shipped on dry ice

Disease-State Bone Marrow Mononuclear Cells

Disease-state BMMCs are available from donors across confirmed hematologic malignancies where the bone marrow is the primary disease site. Each product includes relevant cytogenetic, molecular, and treatment-history donor metadata where documented:

• Acute myeloid leukemia (AML) BMMCs — marrow blast percentage, FLT3 / NPM1 / CEBPA / TP53 status
• Acute lymphoblastic leukemia (ALL) BMMCs — B- versus T-lineage, Philadelphia chromosome status
• Chronic myeloid leukemia (CML) BMMCs — BCR-ABL1, disease phase, TKI treatment history
• Chronic lymphocytic leukemia (CLL) BMMCs — IGHV mutation status, del(17p) / del(11q), infiltration pattern
• Myelodysplastic syndrome (MDS) BMMCs — IPSS-R risk category, blast percentage, SF3B1 / TET2 / ASXL1
• Myeloproliferative neoplasm (MPN) BMMCs — subtype, JAK2 / CALR / MPL driver status
• Myelofibrosis BMMCs — marrow fibrosis grade, driver mutation status, DIPSS risk
• Multiple myeloma BMMCs — FISH cytogenetic risk group, R-ISS stage, plasma cell percentage

Product Features

• Human bone marrow mononuclear cells for Research Use Only (RUO)
• Density-gradient purified and cryopreserved for viability
• IRB-approved protocols and informed consent
• BMMCs from healthy and disease-state donors
• Custom cell quantities available upon request
• Age-matched, sex-matched, and disease-matched donor sets available for case-control study designs

De-identified Donor Data

• Demographic data: age, sex assigned at birth, race/ethnicity
• Physician- or specialist-confirmed diagnosis (healthy or disease-state)
• Donor-reported medications, comorbidities, and allergies
• Infectious disease marker testing results

Applications

• Minimal residual disease (MRD) detection and monitoring assay development
• Hematopoietic stem and progenitor cell biology research
• Immunophenotyping and blast marker studies
• CAR-T and bispecific antibody target-expression studies
• Marrow microenvironment and disease mechanism research
• Cytogenetic and molecular risk-stratification studies

Other Specimen Types

For matched material from the same donor pool, see our human plasma, human serum, human whole blood, human PBMCs, and human leukopak collections.

Compliance and Quality Assurance

• IRB-approved and HIPAA-compliant protocols
• Electronic informed consent with 21 CFR Part 11–compliant e-signatures
• Documentation and regulatory support available upon request

Bone Marrow Biospecimen Suppliers for Research Programs

Work with Sanguine as your bone marrow mononuclear cell supplier for research-ready samples, custom donor criteria, and documentation support. Our biorepository spans healthy controls plus confirmed hematologic malignancy conditions.

Ordering and Customization

Purchase human bone marrow mononuclear cells in standard or custom cell quantities to meet your study requirements. For international orders or documentation needs, please contact our team to confirm regulatory compatibility.

Frequently Asked Questions About Buying Bone Marrow Mononuclear Cells

Where can I buy human bone marrow mononuclear cells for research?

Browse the disease-specific BMMC products listed above or request a quote. Sanguine sources BMMCs from healthy and disease-state donors for hematology and oncology research.

Do you supply normal human BMMCs as a control?

Yes — normal (healthy) human BMMCs are available and can be age- and sex-matched to a disease cohort for case-control work.

What is the difference between BMMCs and PBMCs?

BMMCs are isolated from bone marrow aspirate and contain the full hematopoietic stem and progenitor cell hierarchy; PBMCs are isolated from peripheral blood and primarily contain mature lymphocytes and monocytes. Marrow-based diseases require BMMCs for accurate diagnosis and study.

How much do bone marrow mononuclear cells cost?

BMMC pricing depends on donor diagnosis, cell quantity, and disease-specific screening requirements. Request a quote for current pricing.